Safety and Efficacy of UC-MSCs in Patients With Psoriasis Vulgaris

Summary

The purpose of this study is to investigate the safety and efficacy of umbilical cord derived mesenchymal stem cells (UC-MSCs) in patients with moderate to severe psoriasis vulgaris. Any adverse events related to UC-MSCs infusion will be monitored and the patients will be assessed by Psoriasis Activity and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) in the baseline and after MSCs infusions.

Timeline

Start

2015-04

Primary completion

2016-12

Completion

2016-12

Drugs

Indications